Evidence map›Paper›PMID 36146778›Full record

ArticleViruses2022

Takotsubo Syndrome during COVID-19 Pandemic in the Veneto Region, Italy.

Marco Zuin, Giacomo Mugnai, Maurizio Anselmi, Stefano Bonapace, Paolo Bozzini, Fabio Chirillo, Ada Cutolo, Giuseppe Grassi, Daniela Mancuso, Samuele Meneghin and 17 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 11 institutions in 1 country.

Marco ZuinDivision of Cardiology, West Vicenza General Hospitals, Via del Parco 1, 36071 Arzignano-Vicenza, Italy.
Giacomo MugnaiDivision of Cardiology, West Vicenza General Hospitals, Via del Parco 1, 36071 Arzignano-Vicenza, Italy.
Maurizio AnselmiDepartment of Cardiology, Fracastoro Hospital, 37020 San Bonifacio-Verona, Italy.
Stefano BonapaceDepartment of Cardiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar-Verona, Italy.
Paolo BozziniDepartment of Cardiology, Fracastoro Hospital, 37020 San Bonifacio-Verona, Italy.
Fabio ChirilloDepartment of Cardiology, San Bassiano Hospital, 36061 Bassano-Vicenza, Italy.
Ada CutoloDepartment of Cardiology, All'Angelo Hospital, 30174 Mestre-Venezia, Italy.
Giuseppe GrassiDepartment of Cardiology, Santi Giovanni & Paolo Hospital, 30122 Venezia, Italy.
Daniela MancusoDepartment of Cardiology, Padua University Hospital, 35100 Padova, Italy.
Samuele MeneghinDepartment of Cardiology, Padua University Hospital, 35100 Padova, Italy.
Giulio MolonDepartment of Cardiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar-Verona, Italy.ORCID 0000-0001-8287-0461
Antonio MugnoloDepartment of Cardiology, Legnago General Hospital, 37045 Legnago-Verona, Italy.
Ivan PantanoDepartment of Cardiology, Chioggia General Hospital, 30015 Chioggia-Venezia, Italy.
Angela PoloDepartment of Cardiology, San Bassiano Hospital, 36061 Bassano-Vicenza, Italy.
Paola PuritaDepartment of Cardiology, Mirano General Hospital, 30035 Mirano-Venezia, Italy.
Loris RonconDepartment of Cardiology, Rovigo General Hospital, 45100 Rovigo, Italy.
Salvatore SaccàDepartment of Cardiology, Mirano General Hospital, 30035 Mirano-Venezia, Italy.
Daniele ScarpaDepartment of Cardiology, Santi Giovanni & Paolo Hospital, 30122 Venezia, Italy.
Domenico TavellaDepartment of Cardiology, Verona University Hospital, 37100 Verona, Italy.
Sakis ThemistoclakisDepartment of Cardiology, All'Angelo Hospital, 30174 Mestre-Venezia, Italy.
Giovanni TurianoDepartment of Cardiology, San Donà General Hospital, 30027 San Donà di Piave-Venezia, Italy.
Roberto ValleDepartment of Cardiology, Chioggia General Hospital, 30015 Chioggia-Venezia, Italy.
Maddalena WidmannDepartment of Cardiology, Verona University Hospital, 37100 Verona, Italy.ORCID 0000-0002-6764-9694
Edlira ZakjaDepartment of Cardiology, San Donà General Hospital, 30027 San Donà di Piave-Venezia, Italy.
Alberto ZamboniDepartment of Cardiology, Legnago General Hospital, 37045 Legnago-Verona, Italy.
Gianluca RigatelliDepartment of Cardiology, Madre Teresa di Calcutta Hospital, 35043 Schiavonia-Padova, Italy.ORCID 0000-0003-0920-5021
Claudio BilatoDivision of Cardiology, West Vicenza General Hospitals, Via del Parco 1, 36071 Arzignano-Vicenza, Italy.ORCID 0000-0003-3474-0579
International Renal Research Institute of Vicenza · ITAzienda Ospedaliera Ospedale Civile di Legnano · ITOspedale dell' Angelo · ITOspedale di Mirano · ITOspedale di San Donà di Piave · ITOspedale Sacro Cuore Don Calabria · ITOspedale San Bassiano · ITUniversity of Padua · ITUniversity of Verona · ITOspedale Santa Maria della Misericordia di Rovigo · ITSanta Maria Nuova Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: During the COVID-19 pandemic, the risk of SARS-CoV-2 infection, the public health measures of social distancing, the freedom limitations, quarantine, and the enforced homeworking under the lockdown period, as well as medical causes including COVID-19 infection per se, may have caused major emotional distress, especially in the most vulnerable patients. We aimed to evaluate the variations in the number of admissions due to Takotsubo syndrome (TTS) during the COVID-19 pandemic in the Veneto region. Methods: We retrospectively reviewed and analyzed the number of admissions because of TTS in 13 Divisions of Cardiology located in the Veneto region, the northeastern area of Italy, covering a population of more than 2.5 million inhabitants, during the two major pandemic waves of COVID-19 (the first between 15 March and 30 April 2020 and the second between 15 November and 30 December 2020) that occurred in 2020. Results: In total, 807 acute coronary syndromes were admitted in the 13 enrolling hospitals. Among these, 3.9% had TTS. Compared to the corresponding 2018 and 2019 time periods, we observed a significant increase in the number of TTS cases (+15.6%, p = 0.03 and +12.5%, p = 0.04, comparing 2018 to 2020 and 2019 to 2020, respectively). Geographical distribution of the TTS cases reflected the broad spread of the SARS-CoV-2 infection with a significant direct relationship between TTS incidence and the number of COVID-19 infections according to Pearson’s correlation (r = 0.798, p < 0.001). Conclusions: The higher incidence of TTS during the 2020 COVID-19 pandemic waves, especially in the areas that were hit hardest in terms of morbidity and mortality by the SARS-CoV-2 infection, suggest a strong direct and/or indirect role of COVID-19 in the pathogenesis of TTS.

Indexed as

COVID-19Takotsubo CardiomyopathyCommunicable Disease ControlHumansItalyPandemicsRetrospective StudiesSARS-CoV-2COVID-19epidemiologyTakotsubo

Identifiers

PMID36146778
PMCPMC9506046
OpenAlexW4295094943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.